... References Exdensur (Depemokimab) Approved by US FDA for the Treatment of Severe Asthma — GSK Management of the Patient With Eosinophilic Asthma: A New Era Begins — ERJ Open Research Severe Eosinophilic Asthma — Journal of Clinical Medicine Exdensur (Depemokimab-Ulaa) Injection, for Subcutaneous Use — GlaxoSmithKline ...
Twice-Yearly Injection Approved for Severe Eosinophilic Asthma
... References Exdensur (Depemokimab) Approved by US FDA for the Treatment of Severe Asthma — GSK Management of the Patient With Eosinophilic Asthma: A New Era Begins — ERJ Open Research Severe Eosinophilic Asthma — Journal of Clinical Medicine Exdensur (Depemokimab-Ulaa) Injection, for Subcutaneous Use — GlaxoSmithKline ...